These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757 [TBL] [Abstract][Full Text] [Related]
6. Resection of adrenocortical carcinoma liver metastasis: is it justified? Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905 [TBL] [Abstract][Full Text] [Related]
7. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC; Port JL; Paul S; Stiles BM; Altorki NK Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience. Tritos NA; Cushing GW; Heatley G; Libertino JA Am Surg; 2000 Jan; 66(1):73-9. PubMed ID: 10651352 [TBL] [Abstract][Full Text] [Related]
9. Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patients. op den Winkel J; Pfannschmidt J; Muley T; Grünewald C; Dienemann H; Fassnacht M; Allolio B Ann Thorac Surg; 2011 Dec; 92(6):1965-70. PubMed ID: 22000277 [TBL] [Abstract][Full Text] [Related]
10. [Adrenal carcinoma. Clinical and anatomopathological prognostic factors]. Boneschi M; Erba M; Beretta L; Miani S; Bortolani EM Minerva Chir; 1998 Mar; 53(3):167-72. PubMed ID: 9617113 [TBL] [Abstract][Full Text] [Related]
11. A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization. Soga H; Takenaka A; Ooba T; Nakano Y; Miyake H; Takeda M; Tanaka K; Hara I; Fujisawa M Urol Int; 2009; 82(2):222-6. PubMed ID: 19322014 [TBL] [Abstract][Full Text] [Related]
12. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Molina JR; Aubry MC; Lewis JE; Wampfler JA; Williams BA; Midthun DE; Yang P; Cassivi SD Cancer; 2007 Nov; 110(10):2253-9. PubMed ID: 17918258 [TBL] [Abstract][Full Text] [Related]
13. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M; Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204 [TBL] [Abstract][Full Text] [Related]
14. Surgical outcome of stage III and IV adrenocortical carcinoma. Ohwada S; Izumi M; Kawate S; Hamada K; Toya H; Togo N; Horiguchi J; Koibuchi Y; Takahashi T; Yamada M Jpn J Clin Oncol; 2007 Feb; 37(2):108-13. PubMed ID: 17277000 [TBL] [Abstract][Full Text] [Related]
15. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838 [TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis. Orlando R; Pelizzo MR; Lirussi F Anticancer Res; 2003; 23(3C):2929-31. PubMed ID: 12926137 [TBL] [Abstract][Full Text] [Related]
17. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review. Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402 [TBL] [Abstract][Full Text] [Related]
18. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ; Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987 [TBL] [Abstract][Full Text] [Related]
19. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195 [TBL] [Abstract][Full Text] [Related]